Hangzhou Tigermed Consulting Co. Ltd. announced that Mr. Wu Hao was appointed as co-president of the Company at the seventeenth meeting of the fourth session of the Board. The term of office of Mr. Wu as co-president will take effect from August 10, 2021 until the expiry of the term of the fourth session of the Board. Mr. Wu Hao, aged 54, joined the Group in January 2020. Mr. Wu has over 17 years of experience in the pharmaceutical industry and has extensive marketing and business development experience. Prior to joining the Group, Mr. Wu served successively as a sales manager and a product/project manager of Schering Plough Pharmaceutical Co. Ltd. from August 1994 to October 1999, product manager of Shanghai Roche Pharmaceutical Co. Ltd. from October 1999 to December 2002, marketing director of Eisai China Inc. from January 2003 to July 2007, director of marketing and business development department of SciClone International Pharmaceutical Co. Ltd. from August 2007 to January 2009 and the general manager of Meixin Insurance Broker (Shanghai) Co. Ltd. from March 2010 to January 2020.